Reduction in peripheral regulatory T cell population in childhood ocular type myasthenia gravis
Takafumi Nishimura +6 more
openalex +1 more source
Chronic myeloid leukemia presenting as paraneoplastic ocular myasthenia gravis [PDF]
P. Kumar +3 more
openalex +1 more source
Preliminary Findings of a Dedicated Ocular Myasthenia Gravis Rating Scale: The OMGRate
Sui H. Wong +7 more
openalex +2 more sources
Clinical case report: combination of endocrine ophthalmopathy and myasthenia gravis: diagnostic and therapeutic difficulties [PDF]
D.S. Atarshchikov1, E.S. Taskina2, D.P. Podkopaeva3, N.I. Kibalina1 1AO GK Medsi, Moscow, Russian Federation 2Chita State Medical Academy, Chita, Russian Federation 3I.M.
D.S. Atarshchikov +3 more
doaj
Ocular Myasthenia Gravis: A Current Overview. [PDF]
Behbehani R.
europepmc +1 more source
Thymectomy in the treatment of ocular myasthenia gravis
Peter Roberts +7 more
openalex +1 more source
Immunotherapy for ocular myasthenia gravis: an observational study in Japan. [PDF]
Narita T +14 more
europepmc +1 more source
What Is Next in Myasthenia Gravis? Insights on Ocular and MuSK Forms from AAN 2025 [PDF]
Bertie Pearcey
openalex +1 more source
Myasthenia Gravis is an autoimmune disease characterized by muscle weakness and early fatigue. Although muscle weakness most frequently affects ocular muscles, its effects on the respiratory muscles lead to a serious condition. Because surgery and stress
Haci Ahmet Alıcı +4 more
doaj
E015 A case of ocular myasthenia gravis seen by rheumatology as suspected mononeuritis multiplex in an adult male shortly after Pfizer-BioNTech SARS-CoV-2 vaccination [PDF]
Alice Storrie +3 more
openalex +1 more source

